Novel Natural Carrier‐Free Self‐Assembled Nanoparticles for Treatment of Ulcerative Colitis by Balancing Immune Microenvironment and Intestinal Barrier
Ulcerative colitis (UC) is a chronic inflammatory illness affecting the colon and rectum, with current treatment methods being unable to meet the clinical needs of ulcerative colitis patients. Although nanomedicines are recognized as promising anti‐inflammatory medicines, their clinical application...
Gespeichert in:
| Veröffentlicht in: | Advanced healthcare materials 2023-12, Vol.12 (31), p.e2301826-n/a |
|---|---|
| Hauptverfasser: | , , , , , , , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | n/a |
|---|---|
| container_issue | 31 |
| container_start_page | e2301826 |
| container_title | Advanced healthcare materials |
| container_volume | 12 |
| creator | Gao, Shan Zheng, Haocheng Xu, Shujing Kong, Jingwei Gao, Feng Wang, Zhijia Li, Yuan Dai, Ziqi Jiang, Xinqi Ding, Xia Lei, Haimin |
| description | Ulcerative colitis (UC) is a chronic inflammatory illness affecting the colon and rectum, with current treatment methods being unable to meet the clinical needs of ulcerative colitis patients. Although nanomedicines are recognized as promising anti‐inflammatory medicines, their clinical application is limited by their high cost and unpredictable safety risks. This study reveals that two natural phytochemicals, berberine (BBR) and hesperetin (HST), self‐assemble directly to form binary carrier‐free multi‐functional spherical nanoparticles (BBR‐HST NPs) through noncovalent bonds involving electrostatic interactions, π–π stacking, and hydrogen bonding. Because of their synergistic anti‐inflammatory activity, berberine–hesperetin nanoparticles (BBR‐HST NPs) exhibit significantly better therapeutic effects on UC and inhibitory effects on inflammation than BBR and HST at the same dose by regulating the immune microenvironment and repairing the damaged intestinal barrier. Furthermore, BBR‐HST NPs exhibit good biocompatibility and biosafety. Thus, this study proves the potential of novel natural anti‐inflammatory nanoparticles as therapeutic agents for UC, which could promote the progress of drug development for UC and eventually benefit patients who suffering from it.
This study introduces berberine and hesperetin nanoparticles (BBR‐HST NPs), binary carrier‐free self‐assembly nanoparticles, as a potential treatment for ulcerative colitis. Demonstrating efficacy in dextran sodium sulfate (DSS)‐induced colitis mice, BBR‐HST NPs also restore the intestinal barrier, microbiota, and immune system. This research offers a promising ulcerative colitis treatment and advances carrier‐free nanodrug development. |
| doi_str_mv | 10.1002/adhm.202301826 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2863302105</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2863302105</sourcerecordid><originalsourceid>FETCH-LOGICAL-c3736-32859b85198318c97e9c6510cc040be1039eee256f2e34d9357e3ef4fa7514d3</originalsourceid><addsrcrecordid>eNqFkbtOHDEUhi2UCBChTYks0aTZjS_jmXG5LFlYiUvBph55PGfAyGNv7JlF2-UR6Hk7niSGhUVKg5vj4ju_vqMfoe-UjCkh7Kdq7roxI4wTWrJ8B-0zKtmI5UJ-2f4zsocOY7wn6eWC5iXdRXu8SJPn2T56uvIrsPhK9UNQFk9VCAbC89_HWQDAN2Db9J_ECF1toUmc80sVeqMtRNz6gBcBVN-B67Fv8W-rIajerABPvTW9ibhe4xNlldPG3eJ51w0O8KXRwYNbmeDd66pyDZ67HmJvXLI42Vh8Q19bZSMcvs0DtJj9WkzPRxfXZ_Pp5GKkecHzEWelkHUpqCw5LbUsQOp0KdGaZKQGSrgEACbylgHPGslFARzarFWFoFnDD9CPTewy-D9Dcqg6EzXYJA1-iBUrc84Jo0Qk9Pg_9N4PISknShJaiCK5JGq8odKVMQZoq2UwnQrripLqpbjqpbhqW1xaOHqLHeoOmi3-XlMC5AZ4MBbWn8RVk9Pzy4_wf7tSp8c</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2901757285</pqid></control><display><type>article</type><title>Novel Natural Carrier‐Free Self‐Assembled Nanoparticles for Treatment of Ulcerative Colitis by Balancing Immune Microenvironment and Intestinal Barrier</title><source>MEDLINE</source><source>Access via Wiley Online Library</source><creator>Gao, Shan ; Zheng, Haocheng ; Xu, Shujing ; Kong, Jingwei ; Gao, Feng ; Wang, Zhijia ; Li, Yuan ; Dai, Ziqi ; Jiang, Xinqi ; Ding, Xia ; Lei, Haimin</creator><creatorcontrib>Gao, Shan ; Zheng, Haocheng ; Xu, Shujing ; Kong, Jingwei ; Gao, Feng ; Wang, Zhijia ; Li, Yuan ; Dai, Ziqi ; Jiang, Xinqi ; Ding, Xia ; Lei, Haimin</creatorcontrib><description>Ulcerative colitis (UC) is a chronic inflammatory illness affecting the colon and rectum, with current treatment methods being unable to meet the clinical needs of ulcerative colitis patients. Although nanomedicines are recognized as promising anti‐inflammatory medicines, their clinical application is limited by their high cost and unpredictable safety risks. This study reveals that two natural phytochemicals, berberine (BBR) and hesperetin (HST), self‐assemble directly to form binary carrier‐free multi‐functional spherical nanoparticles (BBR‐HST NPs) through noncovalent bonds involving electrostatic interactions, π–π stacking, and hydrogen bonding. Because of their synergistic anti‐inflammatory activity, berberine–hesperetin nanoparticles (BBR‐HST NPs) exhibit significantly better therapeutic effects on UC and inhibitory effects on inflammation than BBR and HST at the same dose by regulating the immune microenvironment and repairing the damaged intestinal barrier. Furthermore, BBR‐HST NPs exhibit good biocompatibility and biosafety. Thus, this study proves the potential of novel natural anti‐inflammatory nanoparticles as therapeutic agents for UC, which could promote the progress of drug development for UC and eventually benefit patients who suffering from it.
This study introduces berberine and hesperetin nanoparticles (BBR‐HST NPs), binary carrier‐free self‐assembly nanoparticles, as a potential treatment for ulcerative colitis. Demonstrating efficacy in dextran sodium sulfate (DSS)‐induced colitis mice, BBR‐HST NPs also restore the intestinal barrier, microbiota, and immune system. This research offers a promising ulcerative colitis treatment and advances carrier‐free nanodrug development.</description><identifier>ISSN: 2192-2640</identifier><identifier>ISSN: 2192-2659</identifier><identifier>EISSN: 2192-2659</identifier><identifier>DOI: 10.1002/adhm.202301826</identifier><identifier>PMID: 37681364</identifier><language>eng</language><publisher>Germany: Wiley Subscription Services, Inc</publisher><subject>Anti-inflammatory agents ; Anti-Inflammatory Agents - pharmacology ; Anti-Inflammatory Agents - therapeutic use ; anti‐inflammation ; Berberine ; Berberine - pharmacology ; Berberine - therapeutic use ; Biocompatibility ; carrier‐free spherical nanoparticles ; Colitis, Ulcerative - drug therapy ; Drug development ; Electrostatic properties ; Hesperidin ; Humans ; Hydrogen bonding ; Inflammatory bowel disease ; Inflammatory bowel diseases ; Intestine ; Intestines ; Microenvironments ; Nanoparticles ; Nanoparticles - chemistry ; Patients ; Pharmacology ; Self-assembly ; small molecule phytochemicals ; Ulcerative colitis</subject><ispartof>Advanced healthcare materials, 2023-12, Vol.12 (31), p.e2301826-n/a</ispartof><rights>2023 Wiley‐VCH GmbH</rights><rights>2023 Wiley-VCH GmbH.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c3736-32859b85198318c97e9c6510cc040be1039eee256f2e34d9357e3ef4fa7514d3</citedby><cites>FETCH-LOGICAL-c3736-32859b85198318c97e9c6510cc040be1039eee256f2e34d9357e3ef4fa7514d3</cites><orcidid>0000-0001-6765-9545 ; 0000-0002-6643-8123 ; 0009-0001-7613-1766</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://onlinelibrary.wiley.com/doi/pdf/10.1002%2Fadhm.202301826$$EPDF$$P50$$Gwiley$$H</linktopdf><linktohtml>$$Uhttps://onlinelibrary.wiley.com/doi/full/10.1002%2Fadhm.202301826$$EHTML$$P50$$Gwiley$$H</linktohtml><link.rule.ids>315,782,786,1419,27933,27934,45583,45584</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/37681364$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Gao, Shan</creatorcontrib><creatorcontrib>Zheng, Haocheng</creatorcontrib><creatorcontrib>Xu, Shujing</creatorcontrib><creatorcontrib>Kong, Jingwei</creatorcontrib><creatorcontrib>Gao, Feng</creatorcontrib><creatorcontrib>Wang, Zhijia</creatorcontrib><creatorcontrib>Li, Yuan</creatorcontrib><creatorcontrib>Dai, Ziqi</creatorcontrib><creatorcontrib>Jiang, Xinqi</creatorcontrib><creatorcontrib>Ding, Xia</creatorcontrib><creatorcontrib>Lei, Haimin</creatorcontrib><title>Novel Natural Carrier‐Free Self‐Assembled Nanoparticles for Treatment of Ulcerative Colitis by Balancing Immune Microenvironment and Intestinal Barrier</title><title>Advanced healthcare materials</title><addtitle>Adv Healthc Mater</addtitle><description>Ulcerative colitis (UC) is a chronic inflammatory illness affecting the colon and rectum, with current treatment methods being unable to meet the clinical needs of ulcerative colitis patients. Although nanomedicines are recognized as promising anti‐inflammatory medicines, their clinical application is limited by their high cost and unpredictable safety risks. This study reveals that two natural phytochemicals, berberine (BBR) and hesperetin (HST), self‐assemble directly to form binary carrier‐free multi‐functional spherical nanoparticles (BBR‐HST NPs) through noncovalent bonds involving electrostatic interactions, π–π stacking, and hydrogen bonding. Because of their synergistic anti‐inflammatory activity, berberine–hesperetin nanoparticles (BBR‐HST NPs) exhibit significantly better therapeutic effects on UC and inhibitory effects on inflammation than BBR and HST at the same dose by regulating the immune microenvironment and repairing the damaged intestinal barrier. Furthermore, BBR‐HST NPs exhibit good biocompatibility and biosafety. Thus, this study proves the potential of novel natural anti‐inflammatory nanoparticles as therapeutic agents for UC, which could promote the progress of drug development for UC and eventually benefit patients who suffering from it.
This study introduces berberine and hesperetin nanoparticles (BBR‐HST NPs), binary carrier‐free self‐assembly nanoparticles, as a potential treatment for ulcerative colitis. Demonstrating efficacy in dextran sodium sulfate (DSS)‐induced colitis mice, BBR‐HST NPs also restore the intestinal barrier, microbiota, and immune system. This research offers a promising ulcerative colitis treatment and advances carrier‐free nanodrug development.</description><subject>Anti-inflammatory agents</subject><subject>Anti-Inflammatory Agents - pharmacology</subject><subject>Anti-Inflammatory Agents - therapeutic use</subject><subject>anti‐inflammation</subject><subject>Berberine</subject><subject>Berberine - pharmacology</subject><subject>Berberine - therapeutic use</subject><subject>Biocompatibility</subject><subject>carrier‐free spherical nanoparticles</subject><subject>Colitis, Ulcerative - drug therapy</subject><subject>Drug development</subject><subject>Electrostatic properties</subject><subject>Hesperidin</subject><subject>Humans</subject><subject>Hydrogen bonding</subject><subject>Inflammatory bowel disease</subject><subject>Inflammatory bowel diseases</subject><subject>Intestine</subject><subject>Intestines</subject><subject>Microenvironments</subject><subject>Nanoparticles</subject><subject>Nanoparticles - chemistry</subject><subject>Patients</subject><subject>Pharmacology</subject><subject>Self-assembly</subject><subject>small molecule phytochemicals</subject><subject>Ulcerative colitis</subject><issn>2192-2640</issn><issn>2192-2659</issn><issn>2192-2659</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2023</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqFkbtOHDEUhi2UCBChTYks0aTZjS_jmXG5LFlYiUvBph55PGfAyGNv7JlF2-UR6Hk7niSGhUVKg5vj4ju_vqMfoe-UjCkh7Kdq7roxI4wTWrJ8B-0zKtmI5UJ-2f4zsocOY7wn6eWC5iXdRXu8SJPn2T56uvIrsPhK9UNQFk9VCAbC89_HWQDAN2Db9J_ECF1toUmc80sVeqMtRNz6gBcBVN-B67Fv8W-rIajerABPvTW9ibhe4xNlldPG3eJ51w0O8KXRwYNbmeDd66pyDZ67HmJvXLI42Vh8Q19bZSMcvs0DtJj9WkzPRxfXZ_Pp5GKkecHzEWelkHUpqCw5LbUsQOp0KdGaZKQGSrgEACbylgHPGslFARzarFWFoFnDD9CPTewy-D9Dcqg6EzXYJA1-iBUrc84Jo0Qk9Pg_9N4PISknShJaiCK5JGq8odKVMQZoq2UwnQrripLqpbjqpbhqW1xaOHqLHeoOmi3-XlMC5AZ4MBbWn8RVk9Pzy4_wf7tSp8c</recordid><startdate>20231201</startdate><enddate>20231201</enddate><creator>Gao, Shan</creator><creator>Zheng, Haocheng</creator><creator>Xu, Shujing</creator><creator>Kong, Jingwei</creator><creator>Gao, Feng</creator><creator>Wang, Zhijia</creator><creator>Li, Yuan</creator><creator>Dai, Ziqi</creator><creator>Jiang, Xinqi</creator><creator>Ding, Xia</creator><creator>Lei, Haimin</creator><general>Wiley Subscription Services, Inc</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7QF</scope><scope>7QP</scope><scope>7QQ</scope><scope>7SC</scope><scope>7SE</scope><scope>7SP</scope><scope>7SR</scope><scope>7T5</scope><scope>7TA</scope><scope>7TB</scope><scope>7TM</scope><scope>7TO</scope><scope>7U5</scope><scope>8BQ</scope><scope>8FD</scope><scope>F28</scope><scope>FR3</scope><scope>H8D</scope><scope>H8G</scope><scope>H94</scope><scope>JG9</scope><scope>JQ2</scope><scope>K9.</scope><scope>KR7</scope><scope>L7M</scope><scope>L~C</scope><scope>L~D</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0001-6765-9545</orcidid><orcidid>https://orcid.org/0000-0002-6643-8123</orcidid><orcidid>https://orcid.org/0009-0001-7613-1766</orcidid></search><sort><creationdate>20231201</creationdate><title>Novel Natural Carrier‐Free Self‐Assembled Nanoparticles for Treatment of Ulcerative Colitis by Balancing Immune Microenvironment and Intestinal Barrier</title><author>Gao, Shan ; Zheng, Haocheng ; Xu, Shujing ; Kong, Jingwei ; Gao, Feng ; Wang, Zhijia ; Li, Yuan ; Dai, Ziqi ; Jiang, Xinqi ; Ding, Xia ; Lei, Haimin</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c3736-32859b85198318c97e9c6510cc040be1039eee256f2e34d9357e3ef4fa7514d3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2023</creationdate><topic>Anti-inflammatory agents</topic><topic>Anti-Inflammatory Agents - pharmacology</topic><topic>Anti-Inflammatory Agents - therapeutic use</topic><topic>anti‐inflammation</topic><topic>Berberine</topic><topic>Berberine - pharmacology</topic><topic>Berberine - therapeutic use</topic><topic>Biocompatibility</topic><topic>carrier‐free spherical nanoparticles</topic><topic>Colitis, Ulcerative - drug therapy</topic><topic>Drug development</topic><topic>Electrostatic properties</topic><topic>Hesperidin</topic><topic>Humans</topic><topic>Hydrogen bonding</topic><topic>Inflammatory bowel disease</topic><topic>Inflammatory bowel diseases</topic><topic>Intestine</topic><topic>Intestines</topic><topic>Microenvironments</topic><topic>Nanoparticles</topic><topic>Nanoparticles - chemistry</topic><topic>Patients</topic><topic>Pharmacology</topic><topic>Self-assembly</topic><topic>small molecule phytochemicals</topic><topic>Ulcerative colitis</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Gao, Shan</creatorcontrib><creatorcontrib>Zheng, Haocheng</creatorcontrib><creatorcontrib>Xu, Shujing</creatorcontrib><creatorcontrib>Kong, Jingwei</creatorcontrib><creatorcontrib>Gao, Feng</creatorcontrib><creatorcontrib>Wang, Zhijia</creatorcontrib><creatorcontrib>Li, Yuan</creatorcontrib><creatorcontrib>Dai, Ziqi</creatorcontrib><creatorcontrib>Jiang, Xinqi</creatorcontrib><creatorcontrib>Ding, Xia</creatorcontrib><creatorcontrib>Lei, Haimin</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Aluminium Industry Abstracts</collection><collection>Calcium & Calcified Tissue Abstracts</collection><collection>Ceramic Abstracts</collection><collection>Computer and Information Systems Abstracts</collection><collection>Corrosion Abstracts</collection><collection>Electronics & Communications Abstracts</collection><collection>Engineered Materials Abstracts</collection><collection>Immunology Abstracts</collection><collection>Materials Business File</collection><collection>Mechanical & Transportation Engineering Abstracts</collection><collection>Nucleic Acids Abstracts</collection><collection>Oncogenes and Growth Factors Abstracts</collection><collection>Solid State and Superconductivity Abstracts</collection><collection>METADEX</collection><collection>Technology Research Database</collection><collection>ANTE: Abstracts in New Technology & Engineering</collection><collection>Engineering Research Database</collection><collection>Aerospace Database</collection><collection>Copper Technical Reference Library</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>Materials Research Database</collection><collection>ProQuest Computer Science Collection</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Civil Engineering Abstracts</collection><collection>Advanced Technologies Database with Aerospace</collection><collection>Computer and Information Systems Abstracts Academic</collection><collection>Computer and Information Systems Abstracts Professional</collection><collection>MEDLINE - Academic</collection><jtitle>Advanced healthcare materials</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Gao, Shan</au><au>Zheng, Haocheng</au><au>Xu, Shujing</au><au>Kong, Jingwei</au><au>Gao, Feng</au><au>Wang, Zhijia</au><au>Li, Yuan</au><au>Dai, Ziqi</au><au>Jiang, Xinqi</au><au>Ding, Xia</au><au>Lei, Haimin</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Novel Natural Carrier‐Free Self‐Assembled Nanoparticles for Treatment of Ulcerative Colitis by Balancing Immune Microenvironment and Intestinal Barrier</atitle><jtitle>Advanced healthcare materials</jtitle><addtitle>Adv Healthc Mater</addtitle><date>2023-12-01</date><risdate>2023</risdate><volume>12</volume><issue>31</issue><spage>e2301826</spage><epage>n/a</epage><pages>e2301826-n/a</pages><issn>2192-2640</issn><issn>2192-2659</issn><eissn>2192-2659</eissn><abstract>Ulcerative colitis (UC) is a chronic inflammatory illness affecting the colon and rectum, with current treatment methods being unable to meet the clinical needs of ulcerative colitis patients. Although nanomedicines are recognized as promising anti‐inflammatory medicines, their clinical application is limited by their high cost and unpredictable safety risks. This study reveals that two natural phytochemicals, berberine (BBR) and hesperetin (HST), self‐assemble directly to form binary carrier‐free multi‐functional spherical nanoparticles (BBR‐HST NPs) through noncovalent bonds involving electrostatic interactions, π–π stacking, and hydrogen bonding. Because of their synergistic anti‐inflammatory activity, berberine–hesperetin nanoparticles (BBR‐HST NPs) exhibit significantly better therapeutic effects on UC and inhibitory effects on inflammation than BBR and HST at the same dose by regulating the immune microenvironment and repairing the damaged intestinal barrier. Furthermore, BBR‐HST NPs exhibit good biocompatibility and biosafety. Thus, this study proves the potential of novel natural anti‐inflammatory nanoparticles as therapeutic agents for UC, which could promote the progress of drug development for UC and eventually benefit patients who suffering from it.
This study introduces berberine and hesperetin nanoparticles (BBR‐HST NPs), binary carrier‐free self‐assembly nanoparticles, as a potential treatment for ulcerative colitis. Demonstrating efficacy in dextran sodium sulfate (DSS)‐induced colitis mice, BBR‐HST NPs also restore the intestinal barrier, microbiota, and immune system. This research offers a promising ulcerative colitis treatment and advances carrier‐free nanodrug development.</abstract><cop>Germany</cop><pub>Wiley Subscription Services, Inc</pub><pmid>37681364</pmid><doi>10.1002/adhm.202301826</doi><tpages>17</tpages><orcidid>https://orcid.org/0000-0001-6765-9545</orcidid><orcidid>https://orcid.org/0000-0002-6643-8123</orcidid><orcidid>https://orcid.org/0009-0001-7613-1766</orcidid></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 2192-2640 |
| ispartof | Advanced healthcare materials, 2023-12, Vol.12 (31), p.e2301826-n/a |
| issn | 2192-2640 2192-2659 2192-2659 |
| language | eng |
| recordid | cdi_proquest_miscellaneous_2863302105 |
| source | MEDLINE; Access via Wiley Online Library |
| subjects | Anti-inflammatory agents Anti-Inflammatory Agents - pharmacology Anti-Inflammatory Agents - therapeutic use anti‐inflammation Berberine Berberine - pharmacology Berberine - therapeutic use Biocompatibility carrier‐free spherical nanoparticles Colitis, Ulcerative - drug therapy Drug development Electrostatic properties Hesperidin Humans Hydrogen bonding Inflammatory bowel disease Inflammatory bowel diseases Intestine Intestines Microenvironments Nanoparticles Nanoparticles - chemistry Patients Pharmacology Self-assembly small molecule phytochemicals Ulcerative colitis |
| title | Novel Natural Carrier‐Free Self‐Assembled Nanoparticles for Treatment of Ulcerative Colitis by Balancing Immune Microenvironment and Intestinal Barrier |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-03T13%3A07%3A24IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Novel%20Natural%20Carrier%E2%80%90Free%20Self%E2%80%90Assembled%20Nanoparticles%20for%20Treatment%20of%20Ulcerative%20Colitis%20by%20Balancing%20Immune%20Microenvironment%20and%20Intestinal%20Barrier&rft.jtitle=Advanced%20healthcare%20materials&rft.au=Gao,%20Shan&rft.date=2023-12-01&rft.volume=12&rft.issue=31&rft.spage=e2301826&rft.epage=n/a&rft.pages=e2301826-n/a&rft.issn=2192-2640&rft.eissn=2192-2659&rft_id=info:doi/10.1002/adhm.202301826&rft_dat=%3Cproquest_cross%3E2863302105%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2901757285&rft_id=info:pmid/37681364&rfr_iscdi=true |